A Multicenter, Single-Arm Phase II Study of Pemetrexed Plus Doxorubicin Administered Every 21 Days in Patients With Advanced Breast Cancer
Titel:
A Multicenter, Single-Arm Phase II Study of Pemetrexed Plus Doxorubicin Administered Every 21 Days in Patients With Advanced Breast Cancer
Auteur:
Martin, Miguel Blasinska-Morawiec, Maria Salas, J. Fernando Falcon, Silvia Rolski, Janusz Ferrari, Bruno L. Gulyas, Stephen Liu, Yushan Benhadji, Karim A.